Innovations (1):

• Reduced and Quaternized Psoralens as Photo-Activated Therapeutics (Technology#: 090294-01)

Selected Publications (5):

• 2010. Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunction. Bioorganic & medicinal chemistry letters 20(9):2987-90.
• 2008. Vasopressin antagonists as anxiolytics and antidepressants: recent developments. Recent patents on CNS drug discovery 3(2):77-93.
• 2007. Azetidinones as vasopressin V1a antagonists. Bioorganic & medicinal chemistry 15(5):2054-80.
• 2005. Inhibition of interferon-gamma signaling by a mercurio-substituted dihydropsoralen in murine keratinocytes. Biochemical pharmacology 70(12):1726-34.
• 2002. Mechanisms of growth inhibition in keratinocytes by mercurio-substituted 4',5'-dihydropsoralens. Biochemical pharmacology 63(11):2001-9.